Product Information

EFFEXOR XR 37.5 MG CAPSULE is a brand product labeled by Viatris Specialty LLC, priced at $17.7042 per EA under NDC 58151012577. Its NADAC has been published 102 times since Sep 11, 2024.

FDA first approved this application on Oct 20, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the VENLAFAXINE HYDROCHLORIDE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for EFFEXOR XR 37.5 MG CAPSULE has been published 102 times since Sep 11, 2024, and over the history we have for it it has risen 7.6%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.